Raman Gokal

Q: What Schools Are Affiliated With Raman Gokal

Raman Gokal is affiliated with the following schools: University of Oxford, University of Manchester

Raman Gokal's AcademicInfluence.com Rankings

Raman Gokal

Philosophy

#9381

World Rank

#12933

Historical Rank

Logic

#6361

World Rank

#7873

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Raman Gokal's Degrees

Doctorate Medicine Harvard University
PhD Nephrology Stanford University

Why Is Raman Gokal Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Raman Gokal's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Adult Peritoneal Dialysis-Related Peritonitis Treatment Recommendations: 2000 Update (2000) (426)
Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. (1996) (324)
A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. (1994) (305)
Peritoneal Catheters and Exit-Site Practices toward Optimum Peritoneal Access: 1998 Update (1998) (295)
Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. (1993) (234)
Peritoneal Catheters and Exit -Site Practices: Toward Optimum Peritoneal Access (1993) (229)
The Textbook of Peritoneal Dialysis (1994) (223)
OUTCOME IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS AND HAEMODIALYSIS: 4-YEAR ANALYSIS OF A PROSPECTIVE MULTICENTRE STUDY (1987) (219)
Evaluation and Management of Ultrafiltration Problems in Peritoneal Dialysis (2000) (215)
Peritoneal Catheters and Exit-Site Practices toward Optimum Peritoneal Access: A Review of Current Developments (2005) (192)
Non-medical factors that impact on ESRD modality selection. (1993) (176)
Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. (2000) (169)
ULTRAFILTRATION WITH AN ISOSMOTIC SOLUTION DURING LONG PERITONEAL DIALYSIS EXCHANGES (1987) (161)
Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. (2005) (158)
Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis. (1993) (143)
Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. (1998) (141)
Bone loss in long-term renal transplantation: histopathology and densitometry analysis. (1999) (132)
Comparative mortality from cardiovascular disease in patients with chronic renal failure. (1994) (131)
Quality of life in patients undergoing renal replacement therapy. (1993) (129)
Reviews and Original Articles (1996) (125)
Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload. (1979) (123)
The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. (1994) (118)
Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. (2000) (116)
Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome. (1987) (111)
European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. (2005) (110)
Textbook of Peritoneal Dialysis (2000) (109)
Peritoneal dialysis in the 21st century: an analysis of current problems and future developments. (2002) (99)
Outcomes in peritoneal dialysis and haemodialysis--a comparative assessment of survival and quality of life. (1999) (97)
PERITONITIS IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS Laboratory and Clinical Studies (1982) (97)
Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. (2000) (93)
Peritonitis Occurrence in a Multicenter Study of Icodextrin and Glucose in CAPD (1995) (82)
Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis. (1983) (81)
Treatment Recommendations 1993 Update (1993) (80)
Peritonitis in continuous ambulatory peritoneal dialysis. (1982) (79)
ESRD modality selection into the 21st century: the importance of non medical factors. (1997) (77)
Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. (1993) (77)
European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. (2005) (77)
Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia. (1992) (75)
Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. (1989) (73)
The Referral Pattern of Patients with Esrd is a Determinant in the Choice of Dialysis Modality (1997) (71)
Metabolic and laboratory effects of icodextrin. (2002) (70)
An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole. (1990) (69)
"Eosinophilic" peritonitis in continuous ambulatory peritoneal dialysis (CAPD). (1981) (69)
Multi-centre study on outcome of treatment in patients on continuous ambulatory peritoneal dialysis and haemodialysis. (1987) (69)
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. (1998) (68)
Continuous ambulatory peritoneal dialysis: one year's experience in a UK dialysis unit. (1980) (65)
Positive impact of yoga and pranayam on obesity, hypertension, blood sugar, and cholesterol: a pilot assessment. (2007) (62)
Histological, radiological, and biochemical features of the adynamic bone lesion in continuous ambulatory peritoneal dialysis patients. (1994) (61)
A Randomized Controlled Trial of a Bicarbonate and a Bicarbonate/Lactate-Containing Dialysis Solution in Capd (1997) (61)
Sterile Peritonitis in the Peritoneal Dialysis Patient (2005) (59)
Risk Factors for Non‐ischaemic Foot Ulceration in Diabetic Nephropathy (1991) (58)
Monitoring of iron requirements in renal patients on erythropoietin. (1993) (57)
Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients (2003) (56)
Continuous ambulatory peritoneal dialysis: three years' experience. (1983) (56)
Haemodialysis (1999) (53)
Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end‐stage renal disease (2002) (53)
Peritoneal tuberculosis in patients receiving continuous ambulatory peritoneal dialysis. (2001) (49)
Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis Treatment Recommendations: 1989 Update (1989) (48)
Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume. (1998) (48)
European best practice guidelines for peritoneal dialysis. 8 Nutrition in peritoneal dialysis. (2005) (47)
Continuous Ambulatory Peritoneal Dialysis and Renal Transplantation: A Ten-Year Experience in a Single Center (1992) (47)
The Oxford-Manchester study of dialysis patients. Age, risk factors and treatment method in relation to quality of life. (1990) (46)
Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis?: The role for 'colloid' osmosis. (1993) (46)
Treatment of Adult Patients with Renal Failure: Recommended Standards and Audit Measures (1995) (44)
Impact of increasing dialysis volume on adequacy targets: a prospective study. (1997) (44)
Limitations of kinetic models as predictors of nutritional and dialysis adequacy in continuous ambulatory peritoneal dialysis patients. (1993) (44)
Peripheral skin necrosis complicating beta-blockage. (1979) (43)
Peritonitis Occurrence in a Multicenter Study of Icodextrin and Glucose in Capd (1995) (42)
Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. (1993) (42)
Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients? (1996) (42)
Cadaver renal transplantation without maintenance steroids. (1989) (40)
Gustatory Sweating in Diabetes Mellitus (1996) (40)
Kinetic and clinical studies of beta 2-microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer. (1990) (40)
Morbidity and mortality in redefining adequacy of peritoneal dialysis: a step beyond the National Kidney Foundation Dialysis Outcomes Quality Initiative. (1999) (39)
Peritoneal Dialysis Access. Prospective Randomized Trial of 3 Different Peritoneal Catheters Preliminary Report (1994) (38)
Peritonitis associated with vaginal leakage of dialysis fluid in continuous ambulatory peritoneal dialysis. (1982) (38)
European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis. (2005) (37)
Side-effects of antituberculosis drug treatment in patients with chronic renal failure (2002) (36)
Is Long Term Technique Survival on Continuous Ambulatory Peritoneal Dialysis Possible? (1996) (36)
Methylprednisolone in patients with membranous nephropathy and declining renal function. (1987) (35)
Single daily overnight (12-h dwell) use of 7.5% glucose polymer (Mw 18700; Mn 7300) +0.35% glucose solution: a 3-month study. (1993) (35)
EVIDENCE THAT MATCHING FOR HLA ANTIGENS SIGNIFICANTLY INCREASES TRANSPLANT SURVIVAL IN 1001 RENAL TRANSPLANTS PERFORMED IN THE NORTHWEST REGION OF ENGLAND (1989) (35)
The association of renal amyloidosis with regional enteritis (Crohn's disease)--report of two cases and review of the literature. (1980) (34)
The influence of small solute clearance on dietary protein intake in continuous ambulatory peritoneal dialysis patients: a methodologic analysis based on cross-sectional and prospective studies. (1996) (34)
What Is the Evidence That Peritoneal Dialysis Is Underutilized as an ESRD Therapy? (2002) (32)
Icodextrin in Peritoneal Dialysis: Early Development and Clinical Use (1994) (32)
Improved solutions for peritoneal dialysis: physiological calcium solutions, osmotic agents and buffers. (1992) (31)
Healthcare systems. An international review. Introduction. (1999) (31)
The pharmacokinetics of single doses of metoclopramide in renal failure (2004) (31)
Quality of Life in CAPD, Transplant, and Chronic Renal Failure Patients with Diabetes (2007) (30)
Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site. (2004) (29)
Nutrition and peritoneal dialysis. (1998) (29)
The Referral Pattern of End-Stage Renal Disease Patients and the Initiation of Dialysis: A European Perspective (1999) (28)
Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations. (1996) (28)
Renal transplantation in patients on continuous ambulatory peritoneal dialysis. (1981) (27)
ISPD AD HOC Committee on Ultrafiltration Management in Peritoneal Dialysis (2000) (27)
Peritoneal dialysis (1999) (27)
Natural history and prognostic factors of diabetic nephropathy in type 2 diabetes. (2002) (27)
Successful pregnancy in acute monocytic leukaemia. (1976) (26)
Icodextrin-Associated Sterile Peritonitis (2002) (26)
End-stage renal disease in Indo-Asians in the North-West of England. (2003) (25)
Hyperlipidaemia Following Renal Transplantation (1979) (25)
Treatment of hyperlipidaemia in patients on chronic haemodialysis. (1978) (25)
Continuous ambulatory peritoneal dialysis (CAPD) peritonitis treatment recommendations: 1989 update. The Ad Hoc Advisory Committee on Peritonitis Management. (1989) (25)
Dietary treatment of hyperlipidemia in chronic hemodialysis patients. (1978) (24)
Effect of low-dose cyclosporin on plasma lipoproteins and markers of cholestasis in patients with psoriasis. (1995) (24)
Outcome of pregnancy following renal transplantation. (2000) (24)
European best practice guidelines for peritoneal dialysis. 6 Automated peritoneal dialysis. (2005) (24)
Energy metabolism during CAPD: a controlled study. (1995) (24)
Familial membranous nephropathy. (1984) (24)
Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis. (2004) (23)
Newer peritoneal dialysis solutions. (2000) (23)
The repositioning of migrated Tenckhoff continuous ambulatory peritoneal dialysis catheters under fluoroscopic control. (1999) (23)
Glucose polymer as an osmotic agent in CAPD. (1989) (23)
Quality of life of high-risk and elderly dialysis patients in the UK (1987) (23)
Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis. (1993) (23)
Does catheter immobilization reduce exit-site infections in CAPD patients? (1992) (22)
The Impact of Peritoneal Permeability and Residual Renal Function on Pd Prescription (1996) (22)
Natural History of Staphylococcus Aureus Nasal Carriage and its Relationship to Exit- Site Infection (1998) (22)
Iron induced increase in red cell size in haemodialysis patients. (1979) (22)
Towards Tailored Dialysis Fluids in Capd the Role of Reduced Calcium and Magnesium in Dialysis Fluids (1992) (22)
A solutions portfolio approach in peritoneal dialysis. (2003) (22)
A United Kingdom Multicenter Study of Icodextrin in Continuous Ambulatory Peritoneal Dialysis (1994) (21)
Is there a role for adjuvant therapy in patients being treated with epoetin (1999) (21)
Continuous ambulatory peritoneal dialysis (CAPD)--ten years on. (1987) (21)
Taking Peritoneal Dialysis beyond the Year 2000 (1999) (20)
A Prospective, Randomized Study of the Comparative Safety and Efficacy of Intraperitoneal Imipenem versus Vancomycin and Netilmicin in the Treatment of Peritonitis on CAPD (1995) (20)
Imaging in the Dialysis Patient: Dialysis Therapies for End‐Stage Renal Disease (2002) (19)
Optimal Use of Glucose Polymer (Icodextrin) in Peritoneal Dialysis (1996) (18)
Renal papillary necrosis after aspirin and alclofenac. (1977) (18)
Increased Mortality Due to Cardiovascular Disease in Type 1 Diabetic Patients Transplanted for End‐stage Renal Failure (1994) (17)
Long-term CAPD--some U.K. experience. (1988) (17)
Circulating maltose and isomaltose in chronic renal failure. (1987) (16)
Influence of blood volume on the blood pressure of predialysis and peritoneal dialysis patients treated with erythropoietin. (1993) (16)
Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients. (1992) (16)
Association of sex hormone status with the bone loss of renal transplant patients. (2001) (16)
Paediatric continuous ambulatory peritoneal dialysis. (1982) (16)
Rabbit anti-thymocyte globulin treatment of steroid resistant rejection in renal allograft recipients immunosuppressed with cyclosporine A. (1989) (16)
Fluid Management and Cardiovascular Outcome in Peritoneal Dialysis Patients (1999) (16)
Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis. (1992) (15)
Comparative evaluation of CAPD and PD-plus effectiveness. (1999) (15)
European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions. (2005) (15)
Opsonizing Capacity of Peritoneal Fluid and Relationship to Peritonitis in CAPD Patients (1986) (15)
Peritoneal dialysis immediately post transplantation. (1999) (15)
Simultaneous occurrence of IgA nephropathy and sarcoidosis in the context of pre-existent minimal change nephrotic syndrome. (1993) (15)
A trial of subcutaneous administration of darbepoetin alfa once every other week for the treatment of anemia in peritoneal dialysis patients. (2004) (15)
Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid. (1992) (15)
Limitations of the peritoneal equilibration test in prescribing and monitoring dialysis therapy. (1995) (15)
Renal Osteodystrophy in Continuous Ambulatory Peritoneal Dialysis (1981) (14)
European best practice guidelines for peritoneal dialysis. 9 PD and transplantation. (2005) (14)
Does CAPD provide adequate dialysis? (1995) (14)
Peritoneal Dialysis (2000) (14)
METOCLOPRAMIDE IN RENAL FAILURE (1980) (14)
Vancomycin-Resistant Enterococci and Empirical Vancomycin for Capd Peritonitis (1997) (14)
Peritoneal Dialysis in Asia in the 21St Century: Perspectives on and Obstacles to Peritoneal Dialysis Therapy in Asian Countries (2002) (14)
Hyperlipidaemia following renal transplantation. A study of the prevalence, 'natural history' and dietary treatment. (1979) (14)
Historical developments and overview of peritoneal dialysis (1994) (13)
Functional iron deficiency during erythropoietin treatment. (1992) (13)
European best practice guidelines for peritoneal dialysis. 4 Continuous ambulatory peritoneal dialysis delivery systems. (2005) (13)
Renal osteodystrophy and aluminum bone disease in CAPD patients. (1988) (12)
Dialysis fluid cytotoxicity and inhibition of host defence in cultured human mesothelial cells are neutralized rapidly with incubation in the peritoneum. (1996) (12)
Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin. (1993) (12)
A Message from the New President 1998-2001 (1998) (12)
Does CAPD guarantee adequate dialysis delivery and nutrition. (1994) (12)
Renal osteodystrophy in CAPD. (1991) (11)
Management of Foot Problems in Diabetes (1996) (11)
Dialysis Adequacy and Nutritional Status in Continuous Ambulatory Peritoneal Dialysis: Is There a Link? (1995) (11)
Cadaveric transplantation. (1993) (11)
Quality of life after peritoneal dialysis (2000) (11)
Sexual and Marital Relationships and Dialysis the Patient's Viewpoint (1987) (11)
New Osmotic Agents for Peritoneal Dialysis: Where We Are and Where We're Going (1991) (11)
Peritoneal Dialysis in the 21 st Century : An Analysis of Current Problems and Future Developments (2001) (11)
The syndrome of inappropriate antidiuretic hormone secretion associated with acute myocardial infarction. (1977) (11)
Cryptococcosis complicating continuous ambulatory peritoneal dialysis. (1989) (10)
Osmotic agents in peritoneal dialysis. (1990) (10)
Peritoneal Dialysis: Global Update (1999) (10)
Nutritional status in peritoneal dialysis (1995) (10)
Use of oral stable strontium to provide an index of intestinal calcium absorption in chronic ambulatory peritoneal dialysis patients. (1992) (10)
Microcurrent Point Stimulation Applied to Lower Back Acupuncture Points for the Treatment of Nonspecific Neck Pain (2017) (10)
Bacillus Circulans Peritonitis in a Patient Treated with CAPD (2004) (9)
Who's for continuous ambulatory peritoneal dialysis? (1993) (9)
Does peripheral neuropathy invariably accompany nephropathy in type 1 diabetes mellitus? (1998) (9)
Early Start to Peritoneal Dialysis: To Start or not to Start? (2000) (9)
Pharmacokinetics of lamivudine in subjects receiving peritoneal dialysis in end-stage renal failure. (2007) (9)
Neuropathy and Quality of Life in Diabetic Continuous Ambulatory Peritoneal Dialysis Patients (1999) (9)
DC Electroacupuncture Effects on Scars and Sutures of a Patient with Postconcussion Pain (2016) (9)
Sclerosing Encapsulating Peritonitis and Other Complications of CAPD Peritonitis (1986) (8)
Icodextrin-associated peritonitis among CAPD patients. (2003) (8)
Long term peritoneal dialysis--is it a reality? (1999) (8)
Peritoneal Dialysis Solutions: Nutritional Aspects (1997) (8)
Is the Correlation between the Normalised Protein Catabolic Rate (Npcr) and Kt/V the Result of Mathematical Coupling? (1994) (8)
An unusual case of retroperitoneal fibrosis. (1993) (8)
Neuromodulating Influence of Two Electroacupuncture Treatments on Heart Rate Variability, Stress, and Vagal Activity. (2020) (8)
COMPARISON BETWEEN THE PLASMA INSULIN AND GLUCOSE RESPONSES TO FIVE DIFFERENT INSULIN REGIMES IN DIABETIC PATIENTS (1977) (7)
Recurrent Peritonitis Associated with Vaginal Leak (1983) (7)
Influence of azathioprine on the ferrokinetics of patients with renal failure before and after treatment with erythropoietin. (1994) (7)
SUCCESSFUL RENAL TRANSPLANTATION OF PATIENTS SENSITIZED FOLLOWING DELIBERATE UNRELATED BLOOD TRANSFUSIONS (1985) (7)
A review of food provision to a renal ward and the proposed appointment of feeding assistants. (1999) (7)
Glucose Polymer (GP) as an Osmotic Agent in Continuous Ambulatory Peritoneal Dialysis (1985) (7)
Peritoneal dialysis fluids for the future : do we have the solution ? (1992) (7)
Capd Overview (1996) (7)
Iron management in patients on rHuEpo (1997) (7)
Late cellular rejection in renal transplant recipients. (1986) (7)
Small Umbilical Hernias in Patients on CAPD (1984) (7)
Adequacy, Nutrition and Outcome in Peritoneal Dialysis; Is There a Link? (1997) (7)
NEPHROTIC SYNDROME AND HAIRY CELL LEUKAEMIA (1985) (6)
New strategies for peritoneal dialysis fluids. (1997) (6)
Alternative osmotic agents. (1989) (6)
Are Adequacy Targets for Peritoneal Dialysis Meaningful? (1999) (6)
Long-term dietary treatment of hyperlipidaemia in patients treated with chronic haemodialysis. (1980) (6)
The association between cytomegalovirus-specific antibodies, lymphocytotoxic antibodies, HLA-DR phenotype, and graft outcome in renal transplant recipients. (1991) (6)
Pancreatic tuberculosis following renal transplantation. (1992) (6)
Calcium content in automated peritoneal dialysis solutions. (1999) (6)
Gastrin levels in chronic renal failure, hemodialysis and renal transplant patients. (1980) (5)
Peritoneal dialysis as the first-choice treatment. (2003) (5)
Effect of radiotherapy on peritoneal function in continuous ambulatory peritoneal dialysis. (1993) (5)
Multi-center Study on the Outcome of Patients on CAPD and Hemodialysis (1986) (5)
Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin. (1999) (5)
Campylobacter jejuni Bacteremia, Peritonitis, and Exacerbation of Chronic Pancreatitis in a Patient on CAPD: Case Report and Literature Review (2000) (5)
History of peritoneal dialysis (2000) (5)
Treatment of infections in peritoneal dialysis. (2003) (5)
Peritoneal Infections, Hernias and Related Complications (1996) (5)
Reversal of osteomyelosclerosis-associated systemic lupus nephritis. (1998) (5)
A collection of problems in CAPD. (1989) (5)
Recent perspectives on peritoneal dialysis. (1993) (4)
Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. (1988) (4)
Detailed Autonomic Nervous System Analysis of Microcurrent Point Stimulation Applied to Battlefield Acupuncture Protocol (2017) (4)
Survey of Continuous Ambulatory Peritoneal Dialysis in the United Kingdom, 1982 (1984) (4)
Minimal-change glomerulonephritis associated with circulating anticoagulant to factor XII. (1980) (4)
Kidney transplantation in the northwest region of England--experience of 1,132 transplants in 21 years. (1989) (4)
Bone biopsy--beyond light microscopy and histodynamics. (1997) (4)
Low Calcium Dialysate with Oral Caco3 in Capd (1991) (4)
European best practice guidelines for peritoneal dialysis. 1 General guidelines. (2005) (4)
PERITONITIS RELATED TO DEFECTIVE CONTINUOUS AMBULATORY PERITONEAL DIALYSIS EQUIPMENT (1982) (4)
Characteristics and Natural History of Adynamic Bone (AB) in Capd (1992) (4)
Introduction: Advances in Peritoneal Dialysis (2000) (3)
PD plus Concept Leads to Significant Increases in Solute Clearances in Anuric CAPD Patients (2002) (3)
Cinacalcet HCl controls secondary hyperparathyroidism (HPT) regardless of gender, race, age, and geography in patients with chronic kidney disease (CKD) receiving dialysis. (2003) (3)
Bedside testing of CAPD fluid for bilirubin to aid diagnosis of visceral perforation. (2005) (3)
Serum lipoprotein (a) (Lp(a)) levels in nephrotic syndrome (NS), CAPD patients and renal transplant (Tx) recipients (1991) (3)
The Preferred Phosphate Binder in Dialysis Patients (1999) (3)
Risks of Tobramycin Use in CAPD Patients with Peritonitis (1981) (3)
Treatment of Chronic Post Surgical Pain Using Micro-current Point Stimulation Applied to C-Section Scars (2019) (2)
RECOVERY AFTER POTENTIALLY LETHAL AMOUNT OF ANTI-FREEZE (1984) (2)
Infectious Complications and Peritonitis and Their Management (2000) (2)
Adequacy targets in peritoneal dialysis. (2004) (2)
Continuous ambulatory peritoneal dialysis (CAPD) — current state in the United Kingdom (1983) (2)
Dietary Treatment of Hyperlipidaemia in Chronic Haemodialysis Patients (1977) (2)
Specific HLA antibody production following renal transplantation. (1987) (2)
Measuring the adequacy of peritoneal dialysis: is there a link with nutrition and outcome? (1996) (2)
Cutaneous Manifestations Heralding Eosinophilic Peritonitis (1984) (2)
Vitamin D therapy in CAPD: what is its role? (1993) (2)
Drug Innovation, Cost‐effectiveness and Management: The Case of Erythropoietin (1989) (2)
Renal bone disease (1999) (2)
The need for standards and audit measures in the treatment of patients with renal failure. (1996) (2)
Successful Joint Care of Continuous Ambulatory Peritoneal Dialysis Patients with Two District General Hospitals (1990) (2)
New peritoneal dialysis solutions (1996) (1)
Experience with vancomycin, aminoglycosides and newer B-lactam antibiotics in CAPD peritonitis (1993) (1)
Savings with the Use of the “Twin Bag” (1992) (1)
Triple therapy improves the survival of cadaver renal allografts affected by acute tubular necrosis. (1989) (1)
Continuous ambulatory peritoneal dialysis (1989) (1)
The need for a multi‐disciplinary approach to diabetic nephropathy (1988) (1)
ITS RELATIONSHIP TO EXIT-SITE INFECTION (1998) (1)
HLA MATCHING IS IMPORTANT FOR CADAVER RENAL TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORIN (1985) (1)
Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis and Exit-Site Infections: Challenges for the Future (1989) (1)
Adequacy, nutrition, and outcome in peritoneal dialysis. (1997) (1)
Opinion: How Much Peritoneal Dialysis is Needed for Optimal Outcomes? (2003) (1)
Icodextrin of its Use in Peritoneal Dialysis (2003) (1)
nutrition in CAPD patients (1994) (1)
The Successful Treatment of Chronic Pain Using Microcurrent Point Stimulation Applied to Scars (2017) (1)
Multi-Center Study of Outcome of Continuous Ambulatory Peritoneal Dialysis and Hemodialysis Patients A 4-Year Analysis (1990) (1)
Factors affecting ultrafiltration in peritoneal dialysis. (1990) (1)
Normal function from a Tenckhoff catheter after a 7-year rest. (1993) (0)
CASE REPORT Cryptococcosis complicating continuous ambulatory peritoneal dialysis (1989) (0)
TAKING PERITONEAL DIALYSIS BEYOND THE YEAR 2000. DISCUSSION (1999) (0)
25. Prospective screening of patients with end-stage renal failure for asymptomatic cardiovascular disease using thallium myocardial imaging (1992) (0)
Thallium 201 Myocardial Imaging in Continuous Ambulatory Peritoneal Dialysis Patients at High Risk of Coronary Artery Disease (1990) (0)
ambulatory peritoneal dialysis . Paediatric continuous (2006) (0)
Is there a value of erythropoietin in pre‐dialysis patients? (1996) (0)
DEFECTS IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS EQUIPMENT (1982) (0)
What Are Common Management Errors in Chronic Peritoneal Dialysis? (1993) (0)
Discussion: session 5. Epidemiologic investigation of special groups* (1981) (0)
The Successful Treatment of Chronic Pain Using Microcurrent Point Stimulation Applied to Battlefield Acupuncture Protocol (2018) (0)
Subject Index, Vol. 13, 1993 (1993) (0)
Plasma lipoproteins and markers of cholestasis in patients with psoriasis treated with low-dose cyclosporin (1994) (0)
Dialysis techniques: peritoneal dialysis (2004) (0)
The Impact of Peritoneal Permeability and Residual Renal Function on PD Prescription (1996) (0)
Malignant nephrosis. (1996) (0)
The referral pattern of ESRD patients and the initiation of dialysis: a European perspective. (1999) (0)
Fundus changes inmesangiocapillar y glomerulonephritis typeII:clinical andfluorescein angiographic findings (1989) (0)
What is new in CAPD? (highlights of the 7th Congress of the International Society of Peritoneal Dialysis, June 1995). (1996) (0)
Peritoneal Dialysis: Case Forum (1996) (0)
Diabetes and ACE inhibitors. (1990) (0)
Peritoneal Dialysis in the ICU: What is its role? (1995) (0)
C-sections impact on maternal and fetal health. Positive outcomes with Micro Point Stimulation of C-section scars (2020) (0)
8.4-02 The development of lymphocytotoxic antibodies following renal transplantation correlates with graft failure (1989) (0)
Irish nephrological society (1993) (0)
Transplant-induced donor-specific antibodies and graft outcome. (1987) (0)
Effect of sensitization on primary cadaveric renal allograft survival following deliberate unrelated blood transfusions (1987) (0)
HOME HEATING AND RENAL FAILURE (1989) (0)
The Use of Hyposmolar Glucose Polymer Solution in Continuous Ambulatory Peritoneal Dialysis A Seven-Day Study (1990) (0)
What is new in CAPD (1996) (0)
Iron Induced Increase in Erythrocyte Size in Haemodialysis Patients (1979) (0)
Ferrokinetics in Azathioprine-Treated Uraemic Patients on Erythropoietin (1990) (0)
Peritonitis: The Most Serious Complication of Continuous Ambulatory Peritoneal Dialysis Results of a Multi-Center Study (1990) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Raman Gokal?

Raman Gokal is affiliated with the following schools: